Fourth Dimension

Publications

Cumulative impact factor: 41.08

Citations: 306

h-Index: 8

i10-index: 7

SCIENTIFIC PUBLICATIONS

  • Srivastava, T. P., Dhar, R., & Karmakar, S. (2025). Looking beyond the ER, PR, and HER2: what’s new in the ARsenal for combating breast cancer? Reproductive Biology and Endocrinology 23, 9 (2025)
  • Srivastava, T. P., Ajmeriya, S., Goel, I., Talukdar, J., Srivastava, A., Parshad, R., Deo, SVS., Mathur, S. R., Gogia, A., Rai, A., Dhar, R., & Karmakar, S. (2024). Prognostic role of Androgen Receptor splice variant 7 (AR-V7) in the pathogenesis of breast cancer. BMC Cancer Nov 13;24(1):1398.
  • Sarkar, S., Srivastava, T. P., Sahoo, O. S., Shankar, A., Rai, A., Pethusamy, K., … & Karmakar, S. (2024). Applications of Quantum Dots in Preventive Oncology. Asian Pacific Journal of Cancer Prevention, 25(3), 747-756.
  • Talukdar, J., Srivastava, T. P., Sahoo, O. S., Karmakar, A., Rai, A. K., Sarma, A., … & Karmakar, S. (2023). Cancer stem cells: Signaling pathways and therapeutic targeting. MedComm–Oncology, 2(4), e62.
  • Srivastava, T. P., Dhar, R., Sahoo, O. S., Aidasani, H., Rai, A., Kumar, A., & Karmakar, S. (2023). Illuminating oncology research by bioluminescent imaging. Asian Journal of Medical Sciences, 14(11).
  • Purkayastha, K., Dhar, R., Pethusamy, K., Srivastava, T., Shankar, A., Rath, G. K., & Karmakar, S. (2023). The issues and challenges with cancer biomarkers. Journal of Cancer Research and Therapeutics, 19(Suppl 1), S20-S35.
  • Talukdar, J., Srivastava, T., Karmakar, A., Purkaystha, K., Goswami, S., Kumar, A., … & Karmakar, S. (2022). Malaria vaccine: The tale of terror, triumph, tyranny, and trust. Asian Journal of Medical Sciences, 13(9), 252-257.
  • Sahoo, O. S., Pethusamy, K., Srivastava, T. P., Talukdar, J., Alqahtani, M. S., Abbas, M., … & Karmakar, S. (2022). The metabolic addiction of cancer stem cells. Frontiers in Oncology, 12, 955892.
  • Dhar, R., Rana, S., Srivastava, T. P., Nayek, A., Sharma, J. B., Kaur, D., … & Karmakar, S. (2022). India’s Opportunities and Challenges in Establishing a Twin Registry: An Unexplored Human Resource for the World’s Second-Most Populous Nation. Twin Research and Human Genetics, 25(3), 156-164.
  • Dhar, R., Seethy, A., Singh, S., Pethusamy, K., Srivastava, T., Talukdar, J., … & Karmakar, S. (2021). Cancer immunotherapy: Recent advances and challenges. Journal of Cancer Research and Therapeutics, 17(4), 834-844.
  • Chattopadhyay, I., Dhar, R., Pethusamy, K., Seethy, A., Srivastava, T., Sah, R., … & Karmakar, S. (2021). Exploring the role of gut microbiome in colon cancer. Applied biochemistry and biotechnology, 193, 1780-1799.
  • Jain, S., Lone, M. R., Goswami, A., Mandal, T., Panda, A. K., Ramteke, P., Srivastava, T., … & Mallick, S. (2021). Lymphoma subtypes in India: a tertiary care center review. Clinical and Experimental Medicine, 21, 315-321.
  • Dhar, R., Pethusamy, K., Singh, S., Mukherjee, I., Seethy, A., Sengupta, B., Srivastava, T., … & Karmakar, S. (2019). Draft genome of Ompok bimaculatus (Pabda fish). BMC Research Notes, 12, 1-3.
  • Dhar, R., Seethy, A., Pethusamy, K., Singh, S., Rohil, V., Purkayastha, K., Srivastava, T., … & Karmakar, S. (2019). De novo assembly of the Indian blue peacock (Pavo cristatus) genome using Oxford Nanopore technology and Illumina sequencing. Gigascience, 8(5), giz038.
  • Ghimire, D., Timilsina, U., Srivastava, T. P., & Gaur, R. (2017). Insights into the activity of maturation inhibitor PF-46396 on HIV-1 clade C. Scientific Reports, 7(1), 43711.

Abstracts

  • Srivastava, T. P., Talukdar, J., Verma, R. K., & Karmakar, S. (2024). Androgen Receptor Isoform V7 (AR-V7): A Promising Biomarker for Prognosticating Breast Cancer Aggressiveness. Cancer Research, 84(9_Supplement), PO1-13.
  • Srivastava, T. P., Talukdar, J., Mathur, S. R., Srivastava, A., Parshad, R., Deo, SVS., Dhar, R., & Karmakar, S. (2023). Molecular profiling in Breast Cancer identifies Androgen Receptor isoform AR-V7 as critical predictor of tumor aggressiveness and outcome. PO094. GBCC 2023
  • Srivastava, T. P., Dhar, R., Mathur, S. R., Srivastava, A., Parshad, R., Deo, SVS., & Karmakar, S. (2022). Clinical correlation of androgen receptor splice variants in breast cancer. 134. ABST-000331 KSMO 2022
  • Srivastava, T. P., Dhar, R., Srivastava, A., Deo, S. V. S., Parshad, R., & Karmakar, S. (2022). Functional characterization of Androgen Receptor splice variants in breast cancer invasion and metastasis. Cancer Research, 82(12_Supplement), 6398-6398.
  • Talukdar, J., Srivastava, T. P., Gogoi, G., Rai, A., Dhar, R., & Karmakar, S. (2022). Oncometabolite profiling identifying estrogen-responsive genes in breast cancer. ASCO Annual Meeting 2022. e1361
  • Jain, S., Lone, M.R., Goswami, A., Mandai, T., Panda, A.K., Ramteke, P., Srivastav, T., Sharma, M.C., Gogia, A., Sharma, A. and Bakhshi, S., 2020. ABCL-299: updated purview of lymphomas in India: a tertiary care centre review. Clinical Lymphoma Myeloma and Leukemia, 20, p.S272.

Preprints

  • Srivastava, T.P., Ajmeriya, S., Goel, I., Talukdar, J., Srivastava, A., Parshad, R., Deo, S.V.S., Mathur, S.R., Gogia, A., Rai, A. and Dhar, R., 2024. Prognostic Role of Androgen Receptor Splice Variant 7 (AR-V7) in the Pathogenesis of Breast Cancer.
  • Dhar, R., Sinha, A.Y., Seethy, A.A., Matta, S.A., Pethusamy, K., Srivastava, T., Singh, S., Mukherjee, I., Sarkar, S., Minocha, R. and Purkayastha, K. Genotypic and antigenic study of SARS-CoV-2 from an Indian isolate.